Dr. Soliman Fakeeh Hospital in Jeddah achieved a new medical milestone by performing the first autologous blood stem cell transplant in the private sector in the Kingdom of Saudi Arabia, for a 55-year-old patient with multiple myeloma, a step that reflects the development of specialized services in the treatment of blood diseases and tumors, and enhances the hospital's position as a leading center for advanced healthcare.

The hospital's stem cell transplant and cell therapy program launched its first operation by performing an autologous blood stem cell transplant for the patient, and the procedure was successful, confirming the program's readiness to provide this type of precise treatment according to the latest international medical standards and protocols.

Dr. Mazen Fakeeh, Chairman of Fakeeh Healthcare Group, affirmed that this achievement represents a qualitative step in the group's journey towards providing the latest specialized medical services, and reflects its ongoing commitment to delivering advanced healthcare according to the best global practices, contributing to enhancing the quality of healthcare within the Kingdom.

Autologous stem cell transplantation is one of the main pillars in the treatment of medically eligible patients with multiple myeloma, as it involves collecting stem cells from the patient after initial treatment, then administering high doses of chemotherapy to eliminate as many cancer cells as possible, before reinfusing the stem cells to rebuild bone marrow and accelerate the recovery of blood cell production. This technique contributes to deepening the response to treatment, prolonging the period of disease control, and improving therapeutic outcomes and patients' quality of life.

For his part, Dr. Ahmed Al-Saeed, Consultant in Hematology and Bone Marrow Transplantation at Dr. Soliman Fakeeh Hospital in Jeddah, explained that the success of the first autologous blood stem cell transplant within the stem cell transplant and cell therapy program reflects the hospital's readiness in terms of medical expertise and specialized equipment, and enables patients to receive this type of advanced treatment within the Kingdom according to the highest international standards.

It is noteworthy that the Oncology Center at Dr. Soliman Fakeeh Hospital in Jeddah is one of the advanced centers in providing comprehensive and integrated care for cancer patients, starting from early diagnosis, through treatment, to follow-up. The center includes a multidisciplinary team of consultants in surgical oncology, medical oncology, radiation therapy, and histopathology, along with specialized nursing staff, psychological support services, and therapeutic nutrition. The team operates within the tumor board model, where each case is discussed to determine the most appropriate treatment plan.

The center offers a wide range of advanced services, including complex and precise oncological surgeries, laparoscopic and robotic oncological surgeries, chemotherapy, immunotherapy, targeted therapy, and radiotherapy with the latest technologies, in addition to early detection programs, comprehensive screenings, and psychological and rehabilitative support services for cancer patients and their families.

This achievement underscores the advanced position of Dr. Soliman Fakeeh Hospital in Jeddah in providing specialized care for oncology and hematology patients, and reflects the readiness of its infrastructure and medical competencies to deliver advanced treatments according to the best global practices, thereby enhancing the quality of healthcare provided to patients.